JNJ and AMGN Related Headlines
Go Back- Morgan Stanley tracks US drug market prescriptions for week ending July 31
- CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
- Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
- Trump to announce prescription drug price agreements
- Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
- FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
JNJ and AMGN Related Press Releases
Go Back- CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
- Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
